ResMed, Inc. (RMD)
218.89
-2.26
(-1.02%)
USD |
NYSE |
Oct 02, 16:00
219.04
+0.14
(+0.07%)
After-Hours: 20:00
ResMed Gross Profit Margin (Quarterly) : 58.12% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 58.12% |
| March 31, 2026 | 61.46% |
| December 31, 2025 | 60.93% |
| September 30, 2025 | 60.56% |
| June 30, 2025 | 59.95% |
| March 31, 2025 | 58.49% |
| December 31, 2024 | 57.74% |
| September 30, 2024 | 57.64% |
| June 30, 2024 | 57.58% |
| March 31, 2024 | 56.94% |
| December 31, 2023 | 54.64% |
| September 30, 2023 | 53.30% |
| June 30, 2023 | 53.92% |
| March 31, 2023 | 54.22% |
| December 31, 2022 | 55.15% |
| September 30, 2022 | 56.07% |
| June 30, 2022 | 56.26% |
| March 31, 2022 | 55.92% |
| December 31, 2021 | 55.49% |
| September 30, 2021 | 55.15% |
| June 30, 2021 | 55.13% |
| March 31, 2021 | 57.21% |
| December 31, 2020 | 56.85% |
| September 30, 2020 | 57.24% |
| June 30, 2020 | 57.27% |
| Date | Value |
|---|---|
| March 31, 2020 | 57.36% |
| December 31, 2019 | 56.86% |
| September 30, 2019 | 56.76% |
| June 30, 2019 | 55.95% |
| March 31, 2019 | 55.74% |
| December 31, 2018 | 56.50% |
| September 30, 2018 | 56.13% |
| June 30, 2018 | 56.26% |
| March 31, 2018 | 56.22% |
| December 31, 2017 | 56.29% |
| September 30, 2017 | 56.11% |
| June 30, 2017 | 56.05% |
| March 31, 2017 | 56.07% |
| December 31, 2016 | 56.07% |
| September 30, 2016 | 56.41% |
| June 30, 2016 | 55.62% |
| March 31, 2016 | 56.25% |
| December 31, 2015 | 57.66% |
| September 30, 2015 | 57.41% |
| June 30, 2015 | 56.80% |
| March 31, 2015 | 58.99% |
| December 31, 2014 | 61.70% |
| September 30, 2014 | 61.83% |
| June 30, 2014 | 62.34% |
| March 31, 2014 | 62.68% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| IDEXX Laboratories, Inc. | 64.07% |
| Accuray, Inc. | 34.76% |
| Micron Solutions, Inc. | -- |
| Eli Lilly & Co. | 85.78% |
| Neogen Corp. | 37.59% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 24.19% |
| Return on Assets | 17.82% |
| Return on Invested Capital | 21.33% |
| Profit Margin (Quarterly) | 26.20% |
| Operating Margin (Quarterly) | 31.06% |
| Return on Net Operating Assets | 23.96% |